These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1122 related items for PubMed ID: 29393146

  • 1. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S, Takeshima F, Akazawa Y, Matsushima K, Minami H, Yamaguchi N, Ohnita K, Isomoto H, Nakao K.
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [Abstract] [Full Text] [Related]

  • 2. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH, Kim MJ, Chang K, Song EM, Hwang SW, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD.
    BMC Gastroenterol; 2017 Oct 23; 17(1):110. PubMed ID: 29061121
    [Abstract] [Full Text] [Related]

  • 3. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J, Yanai S, Nakamura S, Kawasaki K, Akasaka R, Sato K, Toya Y, Asakura K, Gonai T, Sugai T, Matsumoto T.
    World J Gastroenterol; 2018 Oct 14; 24(38):4384-4392. PubMed ID: 30344422
    [Abstract] [Full Text] [Related]

  • 4. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Mak WY, Buisson A, Andersen MJ, Lei D, Pekow J, Cohen RD, Kahn SA, Pereira B, Rubin DT.
    Dig Dis Sci; 2018 May 14; 63(5):1294-1301. PubMed ID: 29468374
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Golovics PA, Gonczi L, Reinglas J, Verdon C, Pundir S, Afif W, Wild G, Bitton A, Bessissow T, Lakatos PL.
    Dig Dis Sci; 2022 Jul 14; 67(7):3089-3095. PubMed ID: 34286411
    [Abstract] [Full Text] [Related]

  • 8. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis.
    Ishida N, Higuchi T, Miyazu T, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K.
    Sci Rep; 2021 Jun 14; 11(1):12431. PubMed ID: 34127687
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
    Takashima S, Kato J, Hiraoka S, Nakarai A, Takei D, Inokuchi T, Sugihara Y, Takahara M, Harada K, Okada H, Tanaka T, Yamamoto K.
    Am J Gastroenterol; 2015 Jun 14; 110(6):873-80. PubMed ID: 25823769
    [Abstract] [Full Text] [Related]

  • 10. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.
    Inflamm Bowel Dis; 2012 Dec 14; 18(12):2218-24. PubMed ID: 22344983
    [Abstract] [Full Text] [Related]

  • 11. Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis.
    Ryu DG, Kim HW, Park SB, Kang DH, Choi CW, Kim SJ, Nam HS.
    Medicine (Baltimore); 2019 Sep 14; 98(36):e17080. PubMed ID: 31490411
    [Abstract] [Full Text] [Related]

  • 12. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K, Riis LB, Elsberg H, Maagaard L, Thorkilgaard T, Sørbye SW, Jakobsen C, Wewer V, Florholmen J, Goll R, Munkholm P.
    Scand J Gastroenterol; 2018 Sep 14; 53(7):825-830. PubMed ID: 29968483
    [Abstract] [Full Text] [Related]

  • 13. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A, Fish J, Carman N, Walters TD, Church PC, Hansen BE, Crowley E, Siddiqui I, Nguyen GC, Kamath BM, Griffiths AM.
    Clin Gastroenterol Hepatol; 2018 Jul 14; 16(7):1098-1105.e1. PubMed ID: 29378308
    [Abstract] [Full Text] [Related]

  • 14. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A, Kormilitzin A, Hinds C, Sexton V, Brain O, Keshav S, Uhlig H, Geddes J, Goodwin G, Peters M, Collins G, Travis S.
    J Crohns Colitis; 2019 Mar 30; 13(4):424-430. PubMed ID: 30445625
    [Abstract] [Full Text] [Related]

  • 15. Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis.
    Kawashima K, Ishihara S, Yuki T, Fukuba N, Oshima N, Kazumori H, Sonoyama H, Yamashita N, Tada Y, Kusunoki R, Oka A, Mishima Y, Moriyama I, Kinoshita Y.
    BMC Gastroenterol; 2016 Apr 12; 16():47. PubMed ID: 27071448
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B.
    World J Gastroenterol; 2017 Dec 14; 23(46):8235-8247. PubMed ID: 29290660
    [Abstract] [Full Text] [Related]

  • 17. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N, Samaan M, Mosli MH, Parker CE, MacDonald JK, Nelson SA, Zou GY, Feagan BG, Khanna R, Jairath V.
    Cochrane Database Syst Rev; 2018 Jan 16; 1(1):CD011450. PubMed ID: 29338066
    [Abstract] [Full Text] [Related]

  • 18. Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study.
    Kim ES, Lee HS, Kim SK, Kim EY, Jang BI, Kim KO, Yang CH, Lee YJ, Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD).
    Scand J Gastroenterol; 2020 Feb 16; 55(2):163-168. PubMed ID: 31984815
    [Abstract] [Full Text] [Related]

  • 19. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
    Fluxá D, Simian D, Flores L, Ibáñez P, Lubascher J, Figueroa C, Kronberg U, Pizarro G, Castro M, Piottante A, Vial MT, Quera R.
    J Dig Dis; 2017 Nov 16; 18(11):634-641. PubMed ID: 28949435
    [Abstract] [Full Text] [Related]

  • 20. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Brandse JF, Bennink RJ, van Eeden S, Löwenberg M, van den Brink GR, DʼHaens GR.
    Inflamm Bowel Dis; 2016 Jun 16; 22(6):1384-90. PubMed ID: 26978724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.